Searched for
DRUG DEVELOPMENT TIMELINE
Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Novo Nordisk uses AI to fast-track drug launches, expand India roleNovo Nordisk is leveraging Artificial Intelligence to significantly speed up new drug launches. The company expects to cut down the time to...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- Vijay sworn in as Tamil Nadu CM: Here's what TVK promised ahead of Assembly pollsTamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- Shocking claim: Ex-JPMorgan Chase banker Chirayu Rana accused of faking family tragedy in lawsuit against Lorna Hajdini — what we knowA former JPMorgan banker allegedly faked his father's death to take bereavement leave. Chirayu Rana then filed a lawsuit against executive ...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
- CDSCO to create 1,500-member scientific cadre to fast-track drug approvalsThe Central Drugs Standard Control Organisation (CDSCO) plans to create a 1,500-member scientific cadre to speed up drug approval timelines...
- Takeda deepens AI drug discovery push with $1.7 billion Iambic dealIambic and Takeda Pharmaceutical have formed a multi-year partnership valued at over $1.7 billion. This collaboration will leverage artific...
- US biosimilar norms to keep local drug cos in good healthWith the new regulations set by the US FDA, the pathway to creating biosimilars will be both faster and more cost-effective. This developme...
- AI-driven drug discovery picks up as FDA pushes to reduce animal testingDrug development software maker Certara, and biotechs such as Schrodinger and Recursion Pharmaceuticals are already using AI to predict how...
- Drugmakers seem to be in no hurry to launch Covid antiviral pill PaxlovidSeveral industry executives and doctors ET spoke to said at the moment, while cases are rising, the need for Paxlovid hasn't been felt as c...
Load More
